¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Forum 2021 (2ÀÏÂ÷) : 2021-08-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Forum 2021 (2ÀÏÂ÷) : 2021-08-28
±³À°ÀÏÀÚ : 2021-08-28
±³À°Àå¼Ò : Æòâ ¾ËÆæ½Ã¾Æ ¸®Á¶Æ®  
±³À°ÁÖÁ¦ : Heart Valve Disease Forum 2021 (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÈäºÎ¿Ü°úÇÐȸ
´ã´çÀÚ : ¹Î¼ºÂù
¿¬¶ôó : 02-365-7869  
À̸ÞÀÏ : chan.min@ghkh.co.kr      
±³À°Á¾·ù : ÈäºÎ¿Ü°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : °­¿øµµ
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 170,000¿ø      
ºñ°í »çÀüµî·Ï: 140,000¿ø ÇöÀåµî·Ï:170,000¿ø*Wetlab(Ãß°¡ºñ¿ë):50,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 08:00~08:20 Interesting Aortic root and Aortic valve surgery cases 1  ±¸¹ÎÁ¤(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 08:20~08:40 Interesting Aortic root and Aortic valve surgery cases 2  ÃÖÁøÈ£(´ëÀüÀ»Áöº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 08:40~09:00 Interesting Aortic root and Aortic valve surgery cases 3  Á¤¼ö·Ã(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 09:00~09:12 Intraoperative evaluation after AV sparing operation (TEE)  ÀÌÁ¾È¯(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 09:12~09:24 Mechanism of Early failure after AV sparing  ±è´ëÈñ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 09:24~09:36 AV sparing operation in acute type A aortic dissection  ¹Ú°èÇö(ºÐ´ç¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 09:36~09:48 AV sparing operation in connective tissue disorder  ¼º±âÀÍ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 09:48~10:00 Management of the complication after root surgery  À̽ÂÇö(¿¬¼¼¼¼ºê¶õ½ºº´¿ø) 
Åä·Ð 08-28 ±×·£µå º¼·ë 10:00~10:30 Panel discussion  ¹Ú¼ºÁØ(Áß¾Ó´ëÇб³º´¿ø) 
È޽Ġ08-28  10:30~11:00 Coffee break  () 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 11:00~11:15 Evaluation of low gradient aortic valve stenosis with minimal contractile reserve : when and how to intervene?  ¹Ú¼ºÁö(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 11:15~11:30 Tissue valve ion among available tissue valves in Korea  È²È£¿µ(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 11:30~11:45 Redo aortic valve replacement vs valve-in-valve technique in the era of TAVI  ±èÈ£Áø(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 11:45~12:00 Anticoagulation after mechanical valve AVR : new concept  Á¤µ¿¼·(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 12:00~12:15 Anticoagulation after tissue valve AVR in the era of NOAC : Is warfarin is mandatory for 3months after AV replacement?  È«±×·ç(¿¬¼¼¼¼ºê¶õ½ºº´¿ø) 
Åä·Ð 08-28 ±×·£µå º¼·ë 12:15~12:50 Panel discussion  ¹ÚÅñÔ(»ï¼º¼­¿ïº´¿ø) 
½Ä»ç 08-28  12:50~14:00 Lunch  () 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 14:00~14:20 A new technique for shaping the Aortic sinuses and conserving dynamism in the remodeling operation  Magdi H. Yacoub(Aswan Heart Centre) 
Åä·Ð 08-28 ±×·£µå º¼·ë 14:20~14:30 Panel discussion  Panels() 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 14:30~14:50 AV sparing using Valsava graft  Ruggero De Paulis(European Hosp.) 
Åä·Ð 08-28 ±×·£µå º¼·ë 14:50~15:00 Panel discussion  Panels() 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 15:00~15:20 Rapid deploy valve assist minimally invasive AVR  Andrew Newcomb(St. Vincent) 
Åä·Ð 08-28 ±×·£µå º¼·ë 15:20~15:30 Panel discussion  ±è¿ëÇÑ(ÀºÆò¼º¸ðº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 15:30~15:42 Paravalvular leakage after valve replacement: device closure or redo surgery?  ÇÑÁÖ¿ë(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 15:42~15:54 Percutaneous MV repair : where we stand? (Cardiologist`s view)  °­µµÀ±(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 15:54~16:06 Percutaneous MV repair : where we stand? (Surgeon`s view)  Á¦Çü°ï(¾ç»êºÎ»ê´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 16:06~16:18 Suturless valve is really superior to conventional valve? : current outcomes of sutuless valve AVR  ±è°æȯ(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-28 ±×·£µå º¼·ë 16:18~16:30 Minimal invasive technique of AVR : current status?  À¯Àç¼®(¼­¿ï¾Æ»êº´¿ø) 
Åä·Ð 08-28 ±×·£µå º¼·ë 16:30~17:00 Panel discussion  ±è¿ëÇÑ(ÀºÆò¼º¸ðº´¿ø) 
±âŸ 08-28 ±×·£µå º¼·ë 17:00~17:20 Adjourn  ±è¿ëÇÑ(ÀºÆò¼º¸ðº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Forum 2021 (2ÀÏÂ÷) : 2021-08-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2021³â ÀÇ·áºÐÀï ¿¹¹æ ¿¬¼ö±³À° : 2021-08-28
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) 2021³â ¼¼ºê¶õ½º Áö¹æ°£Áúȯ ¿¬¼ö°­Á : 2021-08-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 7 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 8 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 114 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 22 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 79 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 13 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 10 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 8 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 28 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 5 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 10 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 2 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 11 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 9 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 13 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷